Itohan Omorodion, MD, MPH, is an internal medicine resident at George Washington University Hospital and a member of the ABC News Medical Unit.
Data availability All data supporting the findings of this study are available from the corresponding authors on reasonable request
A study suggested also that the use of a BP-lowering central sympatholytic drug, moxonidine, might induce a small but significant weight loss, together with a reduction in blood pressure, triglycerides and fasting blood glucose (Chazova and Schlaich, 2010)
PSPeptides compounds are US-manufactured, verified at 99%+ purity through third-party HPLC testing, with batch-specific Certificates of Analysis
It does not bear insurance risk
Apply for this job * indicates a required field